Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $133.75 USD
Change Today +3.64 / 2.80%
Volume 2.0M
VRTX On Other Exchanges
Symbol
Exchange
Mexico
Frankfurt
As of 4:00 PM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ian F. Smith CPA, ACA

Chief Financial Officer and Executive Vice President,Vertex Pharmaceuticals Incorporated
AgeTotal Calculated CompensationThis person is connected to 50 board members in 4 different organizations across 5 different industries.

See Board Relationships
49$15,303,863
As of Fiscal Year 2014

Background*

Mr. Ian F. Smith, CPA, ACA, has been the Chief Financial Officer of Vertex Pharmaceuticals Incorporated since October 2001 and has been its Executive Vice President since February 2006. Mr. Smith serves as a Member of the Executive Team of Vertex Pharmaceuticals Incorporated and holds responsibility for a wide variety of core functions, including Finance, Strategic Communications, Information Systems, Operations and Human Resources. He served as a Senior Vice President ...

Read Full Background

Corporate Headquarters*

50 Northern Avenue
Boston, Massachusetts 02210

United States

Phone: 617-341-6100
Fax: --

Board Members Memberships*

2004-Present
Director and Member of Audit Committee
2006-Present
Independent Director and Chairman of Audit Committee
2007-Present
Director, Chairman of Audit Committee and Member of Nominations & Governance Committee
2008-Present
Director and Chairman of Audit Committee

Education*

BA
Manchester Metropolitan University

Other Affiliations*

Annual Compensation*

Salary$650,000
Total Annual Compensation$650,000

Stock Options*

Restricted Stock Awards$9,865,110
All Other Compensation$12,857
Exercised Options107,624
Exercised Options Value$7,598,771
Exercisable Options50,420
Exercisable Options Value$2,857,403
Unexercisable Options184,133
Unexercisable Options Value$9,287,706
Total Value of Options$19,743,880
Total Number of Options342,177

Total Compensation*

Total Annual Cash Compensation$1,394,107
Total Short Term Compensation$650,000
Other Long Term Compensation$9,877,967
Total Calculated Compensation$15,303,863
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRTX:US $133.75 USD +3.64

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$854.7K
Jean-Jacques Bienaime MBAChairman and Chief Executive Officer
BioMarin Pharmaceutical Inc.
$916.0K
Rakesh Sachdev Chief Executive Officer, President and Director
Sigma-Aldrich Corporation
$1.0M
Herve Hoppenot Chief Executive Officer, President, Director and Member of Non-Management Stock Option Committee
Incyte Corporation
$2.9M
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$830.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERTEX PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.